Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bristol-Myers Squibb Co (BMY) vs Nu Holdings Ltd (NU) Price & Performance

Bristol-Myers Squibb CoTrade
Nu Holdings LtdTrade

Price performance (Past 24H)

Key statistics

Bristol-Myers Squibb Co vs Nu Holdings Ltd — how do they compare? Bristol-Myers Squibb Co trades at $63.61 (market cap $129.94B), while Nu Holdings Ltd trades at $13.67 (market cap $65.94B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals.

BMYNU
Market Cap
$129.94B$65.94B
Sector
HealthFinancials
52-Week High
$65.89$18.76
52-Week Low
$42.60$11.60
Enterprise Value
$163.92B
Dividend Yield
3.96%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Read more on BMY

About Nu Holdings Ltd

Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.

Read more on NU